Skip to main content
North American Spine Society Journal logoLink to North American Spine Society Journal
. 2023 Sep 9;16:100276. doi: 10.1016/j.xnsj.2023.100276

Benefits of lumbar spine fusion surgery reach 10 years with various surgical indications

Leevi A Toivonen a,, Arja Häkkinen b, Liisa Pekkanen c, Kati Kyrölä c, Hannu Kautiainen d,e, Marko H Neva a
PMCID: PMC10570578  PMID: 37840551

Abstract

Background Context

Lumbar spine fusion (LSF) surgery is a viable form of treatment for several spinal disorders. Treatment effects are preferably to be endorsed in real-life settings.

Methods

This prospective study evaluated the 10-year outcomes of LSF. A population-based series of elective LSFs performed at 2 spine centers between January 2008 and June 2012 were enrolled. Surgeries for tumor, acute fracture, or infection, neuromuscular scoliosis, or postoperative conditions were excluded. The following patient-reported outcome measures (PROMs) were collected at baseline, and 1, 2, 5, and 10 years postsurgery: VAS for back and leg pain, ODI, SF-36. Longitudinal measures of PROMs were analyzed using mixed-effects models.

Results

A total of 683 patients met the inclusion criteria, and 630 (92%) of them completed baseline and at least 1 follow-up PROMs, and they constituted the study population. Mean age was 61 (SD 12) years, 69% women. According to surgical indication, patients were stratified into degenerative spondylolisthesis (DS, n=332, 53%), spinal stenosis (SS, n=102, 16%), isthmic spondylolisthesis (IS, n=97, 15%), degenerative disc disease (DDD, n=52, 8%), and deformity (DF, n=47, 7%).

All diagnostic cohorts demonstrated significant improvement at 1 year, followed by a partial loss of benefits by 10 years. ODI baselines and changes at 1 and 10 years were: (DS) 45, −21, and −14; (SS) 51, −24, and −13; (IS) 41, −24, and −20; (DDD) 50, −20, and −20; and (DF) 50, −21, and −16, respectively. Comparable patterns were seen in pain scores. Significant HRQoL achievements were recorded in all cohorts, greatest in physical domains, but also substantial in mental aspects of HRQoL.

Conclusions

Benefits of LSF were partially lost but still meaningful at 10 years of surgery. Long-term benefits seemed milder with degenerative conditions, reflecting the progress of the ongoing spinal degeneration. Benefits were most overt in pain and physical function measures.

Keywords: Lumbar spine fusion, Long-term, Outcome, Patient reported outcomes, PROM, Indication

Background

Lumbar spine fusion (LSF) surgery is an established method in the treatment of several spinal disorders. Its short-term efficacy has been demonstrated in various populations and distinct pathologies [1], [2], [3], [4], [5]. Great share of these surgeries, however, is carried out for degenerative causes, usually presenting with stenosis [6]. Therein, decompression bears an integral part of fusion surgery.

Effects of LSF predominantly consist of pain relief and functional gain resulting in improving health-related quality of life (HRQoL). It has been stated that LSF may grant short-term benefits at the expense of late-term consequences [7]. Occurrence of adjacent segment disease is a major jeopardizer of long-term treatment effect. It may necessitate repeat surgeries, which in turn may at least partially restore the earlier gains [8]. Preservation of the treatment effect is prerequisite for cost-effectiveness and thereby the overall rationale of the method [9].

Most long-term reports of LSF focus on select pathologies or compare treatment modalities [10], [11], [12], [13]. In addition, low response rates encumber many long-term follow-ups [14]. Reports of nonselected, real-life surgical populations are needed to widen perspectives on long-term efficacy of LSF.

In this study, we sought to scrutinize the 10-year outcomes of LSF on pain, disability, and HRQoL across different indications for elective fusion surgery. We hypothesized that the previously reported early benefits of LSF were substantially maintained at a longer follow-up.

Methods

Subjects and surgeries

This study is based on a series of elective LSF surgeries performed in 2 Finnish spine centers (Tampere University Hospital and Jyväskylä Central Hospital) between January 2008 and June 2012. These public hospitals represent an academic institution and a big central hospital, covering both urban and rural communities of 775,000 inhabitants. Due to Finland's national healthcare insurance system, at the data collecting period, all LSF surgeries for this population were performed in these centers. As a result, the study population also features a population-based sample of elective LSF surgeries.

At the outpatient clinic following decision on elective LSF, patients were offered enrollment in a prospective follow-up study. The attending surgeon procured a written, informed consent. Patients with tumor, acute fracture, or infection, neuromuscular scoliosis, and postoperative condition as an indication for surgery were not included.

The surgeon recorded surgical indications and, accordingly, classified patients into degenerative spondylolisthesis (DS), spinal stenosis (SS), isthmic spondylolisthesis (IS), degenerative disc disease (DDD), and deformity (DF). Spinal stenosis and DS cohorts feature spinal stenosis, DS with and SS without DS. Degenerative disc disease patients typically feature severe disc degeneration, frequently with disc bulging and radiculopathy yet without distinct stenosis in magnetic resonance imaging. The deformity cohort features spinal stenosis with degenerative scoliosis, kyphosis, or lateral spondylolisthesis.

Study setting had no interference to surgeries which were carried out according to standard clinical practice. Indications for surgery were similar across both centers. All surgeries were performed by 7 surgeons with experience of 5 to over 10 years in spine surgery. Also, all surgeons had operated together to ensure uniformity of procedures within and between centers. All surgeries were performed through open, posterior midline incision using pedicle screws. Open decompression was always performed in the presence of stenosis. Interbody spacers were used at the surgeons’ discretion. Ethical boards of both study centers had approved the study.

Outcome measures

Treatment effect was evaluated using established patient-reported outcome measures (PROMs). Pain intensity was quantified with visual analogue scale (VAS) (0–100 mm) for back and leg (radicular) pain. Back-related disability was determined using the Finnish validated version 2.0 of the Oswestry Disability Index (ODI) [15,16]. Oswestry Disability Index score ranges between 0 and 100 with higher scores indicating higher levels of disability. Health-related quality of life (HRQoL) was measured with Short-Form 36 (SF-36) [17]. It has 8 domains that can be aggregated to physical (PCS) and mental (MCS) component summary scores. In the process, PCS is positively impacted by physical functioning, role physical, bodily pain, and general health domains and negatively impacted by mental health, vitality, social functioning, and role-emotional domains. Domains impact contrariwise with MCS. Each domain and summary scores range between 0 and 100, higher scores indicating better health. Patients’ baseline status was collected prior surgery, and follow-up data were collected at 1, 2, 5, and 10 years. A reminder letter was sent in a case of missing answers. Questionnaires were administered by study nurses, while postoperative follow-up visits at spine centers occurred at 3 months and 1 year postsurgery.

Statistics

Data are presented as means with standard deviations (SD), medians with interquartile ranges (IQR), or frequencies with percentages. Differences in baseline demographical and clinical data across surgical indications (groups) were compared with one-way ANOVA, Kruskal–Wallis test, chi-square based test, or Fisher-Freeman exact test, as appropriate. Longitudinal measures of PROMs were analyzed using mixed-effects models with an unstructured covariance structure (ie, the Kenward–Roger method for calculating degrees of freedom). We consider fixed effects to include indication for surgery, time, and indication for surgery * time interactions. As the use of mixed models allows for analysis of unbalanced (eg, missing measurements) datasets without imputation, we analyzed all available data, using the full analysis set. Normal distributions were evaluated graphically, and with the Shapiro–Wilk W test. All analyses were performed with Stata 17.0 (StataCorp LP).

Results

During the data collecting period, 795 LSFs were performed in the 2 study centers. Before surgery, only 10 patients declined to participate. A total of 683 patients met the inclusion criteria (Fig. 1). Of those, 630 patients (92%) completed PROMs at baseline and at least 1 follow-up point, and they constituted the study population. At baseline, mean age of subjects was 61 (SD 12) years, 69% women. Demographical and clinical data are outlined in Table 1. A total of 80 (13%) participants died during the 10-year follow-up. A total of 440 subjects completed 10-year PROMs ensuing a 10-year response rate of 72% among then-alive study participants. Ten-year responses covered at least 63% of all performed surgeries meeting inclusion criteria (eligibility of the 10 refusers was not known).

Fig. 1.

Fig 1

Formation of the study population.

Table 1.

Baseline patient demographical and clinical data according to indication for surgery.

DS
N=332
SS
N=102
IS
N=97
DDD
N=52
DF
N=47
p-value
Women, n (%) 266 (80) 65 (64) 44 (45) 24 (46) 32 (68) <.001
Age, mean (SD) 65 (10) 65 (9) 48 (10) 50 (13) 66 (7) <.001
BMI, mean (SD) 28.1 (4.4) 29.0 (4.4) 27.3 (4.0) 26.8 (3.9) 27.4 (4.5) .011
Education years, mean (SD) 11.4 (3.6) 11.5 (4.0) 12.9 (3.5) 13.9 (3.8) 10.2 (2.9) .049
Cohabiting, n (%) 204 (62) 66 (67) 76 (78) 38 (75) 30 (64) .024
Smoking, n (%) 39 (12) 15 (15) 28 (29) 14 (27) 4 (9) <.001
Retired, n (%) 226 (68) 70 (71) 14 (14) 11 (22) 35 (74) <.001
Comorbidities, n (%)
 Cardiovascular 200 (60) 55 (54) 30 (31) 18 (35) 29 (62) <.001
 Diabetes 39 (12) 17 (17) 7 (7) 4 (8) 8 (17) .18
 Rhematoid 39 (12) 12 (12) 1 (1) 1 (2) 10 (21) <.001
 Neurological 9 (3) 4 (4) 4 (4) 0 (0) 1 (2) .65
 Psychiatric 12 (4) 3 (3) 4 (4) 3 (6) 0 (0) .62
 Pulmonary 11 (3) 3 (3) 3 (3) 1 (2) 0 (0) .90
 Cancer 7 (2) 0 (0) 1 (1) 1 (2) 1 (2) .56
Duration of symptoms, years, median (IQR) 10 (3, 20) 10 (6, 20) 10 (5, 20) 7 (3, 15) 10 (3, 22) .074
Predominant symptom, n (%) <.001
 Radicular pain 246 (75) 62 (63) 55 (59) 26 (52) 20 (43)
 Back pain 45 (14) 21 (21) 36 (38) 21 (42) 22 (47)
 Lower limb weakness 36 (11) 16 (16) 3 (3) 3 (6) 5 (11)
Surgery
 Length of fusion, levels (%) <.001
 1–2 257 (77) 41 (40) 91 (94) 35 (67) 15 (33)
 >2 75 (23) 61 (60) 6 (6) 17 (33) 31 (67)
 Interbody fusion, n (%) 39 (12) 4 (4) 58 (60) 14 (27) 10 (21) <.001

DS, degenerative spondylolisthesis; SS, spinal stenosis; IS, isthmic spondylolisthesis; DDD, degenerative disc disease; DF, deformity

SD, standard deviation; IQR, interquartile range; BMI, body mass index.

According to surgical indication, patients distributed as follows: DS: (n=332, 53%); SS: (n=102, 16%); IS (n=97, 15%); DDD (n=52, 8%); and DF (n=47, 7%). Hence, 434 (69%) patients encompassed spinal stenosis (DS + SS). DDD and IS patients were younger and better educated compared to other cohorts. Patients with DS, IS, and DDD most often received short fusions (1-2 levels), whereas SS (without spondylolisthesis), and deformities ensued longer fusions pertaining to wider-ranging pathology. Rate of interbody spacer was highest within IS cohort.

All diagnostic cohorts demonstrated significant decrease in ODI after surgery (Fig. 2), followed by at least marginal upturn over time. The new rise seemed more manifest in patients with DS or SS. In them, the 10-year change in ODI paralleled a reported minimum clinically important change (MCID) of −12.8 points [18].

Fig. 2.

Fig 2

The Oswestry disability index (ODI) at baseline and follow-up according to surgical indication.

Aligned improvements in VAS for back and leg pain (surpassing reported MCIDs of −12 and 16 as extrapolated from the numeric rating scale [18]) were observed throughout follow-up (Fig. 3A and B). All cohorts except IS experienced partial recurrence of back pain, whereas radicular pain partially recurred to all groups.

Fig. 3.

Fig 3

(A) Visual analogue scale (VAS) for back pain at baseline and follow-up according to surgical indication. (B) Visual analogue scale (VAS) for leg pain at baseline and follow-up according to surgical indication.

Significant HRQoL changes followed LSF across all diagnostic cohorts (Table 2). In the domains of SF-36, increase was greatest in physical role, and bodily pain, substantial in physical function, vitality, emotional role, social functioning, and mental health. Only general health domain prevailed negligible. Physical (PCS) and mental component summary scores (MCS) of SF-36 are presented in Fig. 4A and B. Physical component summary scores changes were greater than MCS changes. PCS changes also surpassed the reported MCID of 4.9 [18]. Minimum clinically important changes for MCS or individual domains of SF-36 have not been reported in lumbar surgery settings, authors understand. Physical component summary scores demonstrated a trend of minor loss of initial benefits over time.

Table 2.

Mean SF-36 domains and summary scores at baseline (with SD) and their changes in follow-up (with 95% CIs) according to surgical indications.

SF-36 domains DS
N=332
SS
N=102
IS
N=97
DDD
N=52
DF
N=47
A, Physical functioning
 Baseline 30 (18) 24 (17) 45 (21) 32 (16) 23 (18)
 Change at 1 y 31 (29–34) 24 (20–29) 29 (24–34) 32 (25–38) 21 (14–28)
 Change at 10 y 17 (14–20) 12 (7–18) 22 (17–27) 30 (23–37) 15 (7–23)
B, Role physical
 Baseline 8 (20) 7 (18) 18 (29) 9 (21) 5 (14)
 Change at 1 y 35 (31–40) 26 (17–34) 33 (25–42) 31 (20–43) 20 (8–33)
 Change at 10 y 26 (21–31) 29 (19–39) 40 (31–49) 34 (21–46) 26 (12–40)
C, Bodily pain
 Baseline 27 (16) 21 (14) 29 (17) 21 (13) 22 (17)
 Change at 1 y 30 (28–33) 27 (22–32) 31 (26–36) 33 (26–41) 28 (21–36)
 Change at 10 years 23 (19–26) 24 (18–30) 26 (20–32) 27 (19–35) 30 (21–38)
D, General health
 Baseline 52 (18) 50 (19) 57 (22) 55 (21) 45 (19)
 Change at 1 y 5 (3–7) 3 (-1 to 6) 6 (2–9) 1 (-4 to 6) 5 (0–11)
 Change at 10 y -4 (-6 to -1) -5 (-9 to 0) 1 (-3 to 5) -2 (-8 to 3) 0 (-6 to 6)
E, Mental health
 Baseline 64 (22) 59 (21) 66 (23) 62 (21) 63 (24)
 Change at 1 y 12 (10–14) 12 (8–16) 10 (5–14) 11 (6–17) 12 (6–18)
 Change at 10 y 12 (10–14) 12 (8–16) 10 (5–14) 11 (6–17) 12 (6–18)
F, Vitality
 Baseline 45 (23) 43 (20) 48 (26) 43 (23) 46 (22)
 Change at 1 y 18 (16–21) 16 (12–21) 16 (11–21) 18 (11–24) 15 (9–22)
 Change at 10 y 10 (8–13) 11 (6–17) 11 (6–16) 15 (8–22) 15 (8–23)
G, Social functioning
 Baseline 52 (28) 50 (29) 59 (27) 46 (26) 49 (27)
 Change at 1 y 25 (22–28) 20 (15–26) 20 (15–26) 26 (18–34) 24 (16–33)
 Change at 10 y 17 (14–21) 13 (6–20) 18 (12–24) 25 (16–34) 23 (14–33)
H, Role emotional
 Baseline 40 (43) 38 (42) 55 (43) 48 (44) 44 (42)
 Change at 1 y 26 (21–31) 18 (8–27) 16 (6–25) 15 (2–28) 13 (-1 to 26)
 Change at 10 y 14 (8–20) 20 (9–31) 21 (11–31) 14 (0–28) 11 (-5 to 26)
PCS, Physical component summary
 Baseline 27 (7) 25 (6) 30 (8) 27 (6) 24 (6)
 Change at 1 y 12 (11–13) 9 (7–10) 13 (11–14) 11 (9–14) 8 (6–11)
 Change at 10 y 7 (6–8) 5 (3–8) 10 (8–12) 10 (7–12) 8 (4–11)
MCS, mental component summary
 Baseline 46 (13) 44 (12) 49 (13) 45 (14) 47 (13)
 Change at 1 y 6 (5–7) 6 (4–7) 3 (1–5) 5 (2–8) 5 (2–8)
 Change at 10 y 3 (2–5) 6 (3–8) 3 (0–5) 4 (0–7) 4 (0–8)

DS, degenerative spondylolisthesis; SS, spinal stenosis; IS, isthmic spondylolisthesis; DDD, degenerative disc disease; DF, deformity

SD, standard deviation; CI, confidence interval; SF-36, Short form 36 health survey.

PCS is positively impacted by domains A–D and negatively by E–H. MCS is negatively impacted by A–D and positively by E–H.

Fig. 4.

Fig 4

(A) The physical component summary score (PCS) of Short-Form 36 (SF-36) at baseline and follow-up according to surgical indication. B. The mental component summary score (MCS) of Short-Form 36 (SF-36) at baseline and follow-up according to surgical indication.

Discussion

This prospective study demonstrated clinically meaningful benefits of LSF throughout the 10-year follow-up. Early benefits observed at 1-year were partially lost later. These trends were visible in all diagnostic cohorts.

The present 10-year trajectories in ODI were consistent with prior reports of LSF outcomes for populations with various indications (mean long-term ODI change from −10 to −26) [8,9,19,20]. In their study comparing fusion techniques, Hoy et al. [19] reported 2-year benefits to be preserved at 5 to 10 years Glassman et al. [9] reported stable ODI through the 5-year follow-up of single-level fusions for various indications. Contrasting those, Maruenda et al. [8] found that after initial benefits of fusion for degenerative indications, ODI was reverted to baseline level by 10 years. High occurrence of adjacent segment disease explained this loss of benefit (25% had undergone revision surgery by 10 years, when those having undergone revision were functionally superior to the rest of patients). Also, we have previously reported a 10-year revision rate of 18% for adjacent segment disease in Tampere University Hospital [21]. The population of that study partially overlapped the present one. Accordingly, progressing spinal disease likely plays a key role in recurring symptoms.

Long-term pain score trajectories are reported more sporadically than ODI. With various indications, long-term reduction in back pain of −2.0 to −3.7 (10-point scale) and leg pain of −2.3 to −3.3 have been reported [9],20]. Our results are in line with those. Fairly aligned patterns across ODI and pain scale trajectories highlight the role pain has in functional restrictions stemming from spinal disorders. We suppose the lowest trend of recurring back pain in IS cohort relates to the unique nature of that pathology (single locus vs. wide-ranging degeneration) and also to the youngest age of that cohort. Therefore, the state of overall spinal degeneration is less advanced in that cohort. The modestly rising trend in radicular pain however seemed surprisingly aligned across cohorts.

Measuring HRQoL on par with pain and disability is preferred in outcomes studies [22]. Short Form-36 is one of the most used HRQoL measures, whereof most spine studies report its physical (PCS) and occasionally also mental (MCS) component summary scores. Individual domains are reported infrequently, yet that is increasingly recommended. Obviously, treatment effect is greatest in pain and functional scores, and less prominent in more general QoL scores [23]. Also here, domains of SF-36 related to pain and physical function (physical role, bodily pain, and physical function) demonstrated the greatest part of QoL improvement. Still, the effect on Emotional role was manifest, suggesting the role of LSF in relieving depressive symptoms potentially secondary to spinal condition [24,25]. Long-term PCS changes here were consistent with prior reports on heterogeneous populations by Glassman et al. [9] (10.1) and surpassed those reported by Owens et al. [20] (2.9–5.9). Utility of MCS with spinal disorders typically characterized by physical disability is compromised due to calculation process of MCS where low physical scores boost MSC [26]. Therefore, MCS changes in our cohorts also prevailed modest and inconclusive compared to PCS changes (Fig. 3) in consistence with prior reports [26].

Strengths and limitations

A population-based sample, validated outcome instruments, continuity of follow-up, and logical results are the strengths of this study. The 10-year response rate of 74% constitutes a limitation typical to long-term studies [14]. However, even short-term (1-year) data coverage of some national registries is yet lower [27,28]. Occasionally, outcomes of nonrespondents are anticipated to be worse [29]. However, other reports have appraised the bias from non-respondents limited [30], [31], [32]. Age-related limitations emerge in longer follow-ups: healthy patients at baseline may get dementia and other comorbidities and may even end up in nursing homes during the follow-up, making their participation no longer feasible. Of course, the functional demands of such patients are certainly lower, as well. Also, surgical practices change along with technological advancements. Advanced interbody fusion and minimally invasive techniques have emerged after the data collecting period, but their role in improving clinical outcomes remains to be endorsed, preserving the present results valid so far.

Another limitation of this study is the lack of control cohort treated without surgery. Nevertheless, as the natural course of distinguished spinal stenosis is not favorable, [33,34] we suppose the present results largely represent an actual treatment effect. The prospective follow-up here is predominantly based on PROMs. Long-term course of degenerative spinal complaints may involve repeat surgeries, which however may restore the earlier satisfactory outcomes, at best [8]. Other musculoskeletal disorders may also impact the long-term PROM trajectories. Here, lack of detailed data on complications and reoperations during follow-up restricts interpretation of our results. Exclusion criteria of the present study (fracture, tumor, infection, neuromuscular scoliosis, and postoperative conditions) precludes external validity for those indications.

In the light of above limitations, our results best serve as a real-life evidence of long-term effects of elective LSF surgeries. It is valuable to see aligned while not similar benefits across the spectrum of LSF surgeries. Moreover, benefits were visible still at 10 years despite the fact that a significant share of patients have undergone reoperations by then [8,21]. Present results emphasize the need for careful and shared decision-making for LSF surgeries.

Conclusion

In the present study, patients undergoing elective LSF surgeries were enrolled to a prospective 10-year follow-up. Benefits of LSF on pain, disability, and HRQoL were partially lost but still meaningful at 10 years of surgery. Magnitude and longevity of benefits showed slightly varying trends across surgical indications, although benefits were demonstrated in all diagnostic groups.

Declarations of competing interests

One or more of the authors declare financial or professional relationships on ICMJE-NASSJ disclosure forms.

Funding

This study was not supported by any kind of funding.

Footnotes

FDA device/drug status: Not applicable.

Author disclosures: LAT: Nothing to disclose. AH: Nothing to disclose. LP: Nothing to disclose. KK: Nothing to disclose. HK: Nothing to disclose. MHN: Speaking and/or Teaching Arrangements: AO Spine (chairman and table instructor in courses); DePuy Synthes (lecturer and table instructor in courses) (none); Board of Directors: AO Spine ESA Board (none) (each Level B).

Contributor Information

Leevi A. Toivonen, Email: leevi.toivonen@pirha.fi.

Marko H. Neva, Email: marko.neva@pirha.fi.

References

  • 1.Möller H, Hedlund R. Surgery versus conservative management in adult isthmic spondylolisthesis–a prospective randomized study: part 1. Spine (Phila Pa 1976) 2000;25(13):1711–1715. doi: 10.1097/00007632-200007010-00016. [DOI] [PubMed] [Google Scholar]
  • 2.Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis. N Engl J Med. 2007;356(22):2257–2270. doi: 10.1056/NEJMoa070302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Pekkanen L, Neva MH, Kautiainen H, et al. Changes in health utility, disability, and health-related quality of life in patients after spinal fusion: a 2-year follow-up study. Spine (Phila Pa 1976) 2014;39(25):2108–2114. doi: 10.1097/BRS.0000000000000624. [DOI] [PubMed] [Google Scholar]
  • 4.Fritzell P, Hägg O, Wessberg P, et al. 2001 Volvo Award Winner in clinical studies: lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine (Phila Pa 1976) 2001;26(23):2521–2532. doi: 10.1097/00007632-200112010-00002. discussion 2532-2524. [DOI] [PubMed] [Google Scholar]
  • 5.Kelly MP, Lurie JD, Yanik EL, et al. Operative versus nonoperative treatment for adult symptomatic lumbar scoliosis. J Bone Joint Surg Am. 2019;101(4):338–352. doi: 10.2106/JBJS.18.00483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Martin BI, Mirza SK, Spina N, et al. Trends in lumbar fusion procedure rates and associated hospital costs for degenerative spinal diseases in the United States, 2004 to 2015. Spine (Phila Pa 1976) 2019;44(5):369–376. doi: 10.1097/BRS.0000000000002822. [DOI] [PubMed] [Google Scholar]
  • 7.Ehni G. The role of spine fusion: Question 9. Spine. 1981;6(3):308–310. [Google Scholar]
  • 8.Maruenda JI, Barrios C, Garibo F, Maruenda B. Adjacent segment degeneration and revision surgery after circumferential lumbar fusion: outcomes throughout 15 years of follow-up. Eur Spine J. 2016;25(5):1550–1557. doi: 10.1007/s00586-016-4469-5. [DOI] [PubMed] [Google Scholar]
  • 9.Glassman SD, Polly DW, Dimar JR, Carreon LY. The cost effectiveness of single-level instrumented posterolateral lumbar fusion at 5 years after surgery. Spine (Phila Pa 1976) 2012;37(9):769–774. doi: 10.1097/BRS.0b013e3181e03099. [DOI] [PubMed] [Google Scholar]
  • 10.Lehr AM, Delawi D, van Susante JLC, et al. Long-term (>10 years) clinical outcomes of instrumented posterolateral fusion for spondylolisthesis. Eur Spine J. 2021;30(5):1380–1386. doi: 10.1007/s00586-020-06671-6. [DOI] [PubMed] [Google Scholar]
  • 11.Ekman P, Möller H, Hedlund R. The long-term effect of posterolateral fusion in adult isthmic spondylolisthesis: a randomized controlled study. Spine J. 2005;5(1):36–44. doi: 10.1016/j.spinee.2004.05.249. [DOI] [PubMed] [Google Scholar]
  • 12.Abdu WA, Sacks OA, Tosteson ANA, et al. Long-term results of surgery compared with nonoperative treatment for lumbar degenerative spondylolisthesis in the Spine Patient Outcomes Research Trial (SPORT) Spine (Phila Pa 1976) 2018;43(23):1619–1630. doi: 10.1097/BRS.0000000000002682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Endler P, Ekman P, Möller H, Gerdhem P. Outcomes of posterolateral fusion with and without instrumentation and of interbody fusion for isthmic spondylolisthesis: a prospective study. J Bone Joint Surg Am. 2017;99(9):743–752. doi: 10.2106/JBJS.16.00679. [DOI] [PubMed] [Google Scholar]
  • 14.Wang K, Eftang CN, Jakobsen RB, Aroen A. Review of response rates over time in registry-based studies using patient-reported outcome measures. BMJ Open. 2020;10(8) doi: 10.1136/bmjopen-2019-030808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fairbank JC, Couper J, Davies JB, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66(8):271–273. [PubMed] [Google Scholar]
  • 16.Pekkanen L, Kautiainen H, Ylinen J, et al. Reliability and validity study of the Finnish version 2.0 of the Oswestry Disability Index. Spine (Phila Pa 1976) 2011;36(4):332–338. doi: 10.1097/BRS.0b013e3181cdd702. [DOI] [PubMed] [Google Scholar]
  • 17.Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. [PubMed] [Google Scholar]
  • 18.Copay AG, Glassman SD, Subach BR, et al. Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, medical outcomes study questionnaire Short Form 36, and pain scales. Spine J. 2008;8(6):968–974. doi: 10.1016/j.spinee.2007.11.006. [DOI] [PubMed] [Google Scholar]
  • 19.Høy K, Truong K, Andersen T, Bünger C. Addition of TLIF does not improve outcome over standard posterior instrumented fusion. 5-10 years long-term Follow-up: results from a RCT. Eur Spine J. 2017;26(3):658–665. doi: 10.1007/s00586-016-4592-3. [DOI] [PubMed] [Google Scholar]
  • 20.Owens RK, 2nd, Djurasovic M, Onyekwelu I, et al. Outcomes and revision rates in normal, overweight, and obese patients 5 years after lumbar fusion. Spine J. 2016;16(10):1178–1183. doi: 10.1016/j.spinee.2016.06.005. [DOI] [PubMed] [Google Scholar]
  • 21.Toivonen LA, Mäntymäki H, Häkkinen A, et al. Isthmic spondylolisthesis is associated with less revisions for adjacent segment disease after lumbar spine fusion than degenerative spinal conditions: a 10-Year follow-up study. Spine (Phila Pa 1976) 2022;47(4):303–308. doi: 10.1097/BRS.0000000000004242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.DeVine J, Norvell DC, Ecker E, et al. Evaluating the correlation and responsiveness of patient-reported pain with function and quality-of-life outcomes after spine surgery. Spine (Phila Pa 1976) 2011;36(21 Suppl):S69–S74. doi: 10.1097/BRS.0b013e31822ef6de. [DOI] [PubMed] [Google Scholar]
  • 23.Joelson A, Sigmundsson FG, Karlsson J. Responsiveness of the SF-36 general health domain: observations from 14883 spine surgery procedures. Qual Life Res. 2022;31(2):589–596. doi: 10.1007/s11136-021-02913-2. [DOI] [PubMed] [Google Scholar]
  • 24.Toivonen L, Häkkinen A, Pekkanen L, et al. Influence of depressive symptoms on the outcome of lumbar spine fusion - a 5-year follow-up study. Spine (Phila Pa 1976) 2021;46(6):408–412. doi: 10.1097/BRS.0000000000003803. [DOI] [PubMed] [Google Scholar]
  • 25.Cushnie D, Soroceanu A, Stratton A, et al. Outcome of spine surgery in patients with depressed mental states: a Canadian spine outcome research network study. Spine J. 2022;22(10):1700–1707. doi: 10.1016/j.spinee.2022.05.012. [DOI] [PubMed] [Google Scholar]
  • 26.Laucis NC, Hays RD, Bhattacharyya T. Scoring the SF-36 in orthopaedics: a brief guide. J Bone Joint Surg Am. 2015;97(19):1628–1634. doi: 10.2106/JBJS.O.00030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cunningham G, Wright D, Nnadi CC, Kieser DC. Patient Outcome Questionnaires in the British Spine Registry: Why are response rates low and which patients groups are responding. J Spine Neurosurg. 2020;9(0) [Google Scholar]
  • 28.Alhaug OK, Kaur S, Dolatowski F, et al. Accuracy and agreement of national spine register data for 474 patients compared to corresponding electronic patient records. Eur Spine J. 2022;31(3):801–811. doi: 10.1007/s00586-021-07093-8. [DOI] [PubMed] [Google Scholar]
  • 29.Parai C, Hagg O, Willers C, Lind B, Brisby H. Characteristics and predicted outcome of patients lost to follow-up after degenerative lumbar spine surgery. Eur Spine J. 2020;29(12):3063–3073. doi: 10.1007/s00586-020-06528-y. [DOI] [PubMed] [Google Scholar]
  • 30.Højmark K, Støttrup C, Carreon L, Andersen MO. Patient-reported outcome measures unbiased by loss of follow-up. Single-center study based on DaneSpine, the Danish spine surgery registry. Eur Spine J. 2016;25(1):282–286. doi: 10.1007/s00586-015-4127-3. [DOI] [PubMed] [Google Scholar]
  • 31.Elkan P, Lagerback T, Moller H, Gerdhem P. Response rate does not affect patient-reported outcome after lumbar discectomy. Eur Spine J. 2018;27(7):1538–1546. doi: 10.1007/s00586-018-5541-0. [DOI] [PubMed] [Google Scholar]
  • 32.Ingebrigtsen T, Aune G, Karlsen ME, et al. Non-respondents do not bias outcome assessment after cervical spine surgery: a multicenter observational study from the Norwegian registry for spine surgery (NORspine) Acta Neurochir (Wien) 2023;165(1):125–133. doi: 10.1007/s00701-022-05453-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Johnsson KE, Rosen I, Uden A. The natural course of lumbar spinal stenosis. Clin Orthop Relat Res. 1992;(279):82–86. [PubMed] [Google Scholar]
  • 34.Matsudaira K, Hara N, Oka H, et al. Predictive factors for subjective improvement in lumbar spinal stenosis patients with nonsurgical treatment: a 3-year prospective cohort study. PLoS One. 2016;11(2) doi: 10.1371/journal.pone.0148584. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from North American Spine Society Journal are provided here courtesy of Elsevier

RESOURCES